EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of diabetes-related retinal pathophysiology by PTX3

Varun Pathak iD, Pietro M Bertelli iD, Edoardo Pedrini, Kevin Harkin, Elisa Peixoto, Lynsey-Dawn Allen, Kiran Mcloughlin iD, Natasha D Chavda iD, Kevin J Hamill, Jasenka Guduric-Fuchs iD, Antonio Inforzato iD, Barbara Bottazzi iD und 2 weitere

Proceedings of the National Academy of Sciences · 08.10.2024 · 121 (41)

DOI: 10.1073/pnas.2320034121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.09.2024. Verfasst von Varun Pathak und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, United Kingdom. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Mice, Knockout, Diabetes Mellitus, Experimental, Retina. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk (Novo Nordisk Global), UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), UKRI | Medical Research Council (MRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is a common complication of diabetes characterized by vascular pathology and neuroinflammation. Pentraxin 3 (PTX3) is a soluble pattern recognition molecule that functions at the crossroads between innate immunity, inflammation, and tissue remodeling. DR is known to involve inflammatory pathways, although the potential relevance of PTX3 has not been explored. We found that PTX3 protein levels increased in the retina of diabetic mice. Similarly, evaluation of a publicly available transcriptomic human dataset revealed increased PTX3 expression in DR with diabetic macular edema and proliferative retinopathy, when compared to nondiabetic retinas or diabetic retinas without complications. To further understand the role of PTX3 within DR, we employed the streptozotocin-induced diabetes model in PTX3 knockout mice (PTX3 KO ), which were followed up for 9 mo to evaluate hallmarks of disease progression. In diabetic PTX3 KO mice, we observed decreased reactive gliosis, diminished microglia activation, and reduced vasodegeneration, when compared to diabetic PTX3 wild-type littermates. The decrease in DR–associated pathological features in PTX3 KO retinas translated into preserved visual function, as evidenced by improved optokinetic response, restored b-wave amplitude in electroretinograms, and attenuated neurodegeneration. We showed that PTX3 induced an inflammatory phenotype in human retinal macroglia, characterized by GFAP upregulation and increased secretion of IL6 and PAI-1. We confirmed that PTX3 was required for TNF-α-induced reactive gliosis, as PTX3 KO retinal explants did not up-regulate GFAP in response to TNF-α. This study reveals a unique role for PTX3 as an enhancer of sterile inflammation in DR, which drives pathogenesis and ultimately visual impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyMice, KnockoutDiabetes Mellitus, ExperimentalRetinaC-Reactive ProteinAnimalsMiceHumansSerum Amyloid P-ComponentMaleMice, Inbred C57BLInflammationMicrogliaMacular EdemaNerve Tissue ProteinsPentraxins

Stichwörter der Autor:innen

PTX3diabetic retinopathygliosismicrogliaretinopathy

Substanzen

C-Reactive ProteinSerum Amyloid P-ComponentNerve Tissue ProteinsPentraxins

Autor:innen und Institutionen

  • The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
  • Department for Eye and Vision Sciences, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool L7 8TX, United Kingdom.
  • Laboratory of Cellular and Humoral Innate Immunity, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Rozzano, Milan 20089, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan 20072, Italy.

ORCID-Profile: Varun Pathak, Pietro M Bertelli, Kiran Mcloughlin, Natasha D Chavda, Jasenka Guduric-Fuchs, Antonio Inforzato, Barbara Bottazzi, Alan W Stitt, Reinhold J Medina

Förderung

  • Novo Nordisk (Novo Nordisk Global)
  • UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
  • UKRI | Medical Research Council (MRC)
  • Diabetes UK
  • Macular Society (The Macular Society)
  • EC | European Research Council (ERC)
  • Department for the Economy Northern Ireland

Zitieren

APA

Pathak, V., Bertelli, P. M., Pedrini, E., Harkin, K., Peixoto, E., Allen, L. D., Mcloughlin, K., Chavda, N. D., Hamill, K. J., Guduric-Fuchs, J., Inforzato, A., Bottazzi, B., Stitt, A. W., & Medina, R. J. (2024). Modulation of diabetes-related retinal pathophysiology by PTX3. Proceedings of the National Academy of Sciences, 121(41). https://doi.org/10.1073/pnas.2320034121

Vancouver

Pathak V, Bertelli PM, Pedrini E, Harkin K, Peixoto E, Allen LD, et al. Modulation of diabetes-related retinal pathophysiology by PTX3. Proceedings of the National Academy of Sciences. 2024;121(41). doi:10.1073/pnas.2320034121

BibTeX
@article{Pathak2024,
  author = {Pathak, Varun and Bertelli, Pietro M and Pedrini, Edoardo and Harkin, Kevin and Peixoto, Elisa and Allen, Lynsey-Dawn and Mcloughlin, Kiran and Chavda, Natasha D and Hamill, Kevin J and Guduric-Fuchs, Jasenka and Inforzato, Antonio and Bottazzi, Barbara and Stitt, Alan W and Medina, Reinhold J},
  title = {Modulation of diabetes-related retinal pathophysiology by PTX3},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {41},
  doi = {10.1073/pnas.2320034121}
}
Kostenlos starten →